Phenotypic heterogeneity in 22q11.2 deletion syndrome: Copy Number Variants as genetic modifiers for congenital heart disease in a Brazilian cohort

• Published in: American journal of medical genetics. Part A 2023-05, Vol.191 (5), p.1273-1281
• Main Authors: Zamariolli, M., Dantas, A. G., Nunes, N., Moysés‐Oliveira, M., Sgardioli, I. C., Soares, D. C. Q., Gil‐Da‐Silva‐Lopes, V. L., Kim, C. A., Melaragno, M. I.
• Format: Article
• Language: English
• Subjects: 22q11.2 deletion syndrome; Brazil - epidemiology; Cardiovascular disease; Congenital diseases; congenital heart disease (CHD); Copy number; copy‐number variant (CNV); DiGeorge Syndrome - genetics; DNA Copy Number Variations - genetics; Genetic analysis; genetic modifiers; Genomes; Heart Defects, Congenital - genetics; Heart diseases; Humans; miRNA; Phenotype; Phenotypes; Quality control; Single-nucleotide polymorphism; Ubiquitination
• ISSN: 1552-4825; 1552-4833
• DOI: 10.1002/ajmg.a.63145

The clinical heterogeneity in 22q11.2 deletion syndrome (22q11.2DS) underlies complex genetic mechanisms including variants in other regions of the genome, known as genetic modifiers. Congenital heart disease (CHD) is one of the most relevant phenotypes in the syndrome and copy number variants (CNVs) outside the 22q11.2 region could play a role in its variable expressivity. Since those described loci account for a small proportion of the variability, the CNV analysis in new cohorts from different ancestry‐based populations constitutes a valuable resource to identify a wider range of modifiers. We performed SNP‐array in 117 Brazilian patients with 22q11.2DS, with and without CHD, and leveraged genome‐wide CNV analysis. After quality control, we selected 50 CNVs in 38 patients for downstream analysis. CNVs' genetic content and implicated biological pathways were compared between patients with and without CHD. CNV‐affected genes in patients with CHD were enriched for several functional terms related to ubiquitination, transcription factor binding sites and miRNA targets, highlighting the complexity of the phenotype's expressivity. Cardiac‐related genes were identified in both groups of patients suggesting that increasing risk and protective mechanisms could be involved. These genes and enriched pathways could indicate new modifiers to the cardiac phenotype in 22q11.2DS patients.